Matches any text strings used to describe a molecule.
Systematic Name, Synonym, Trade Name, Registry Number, SMILES, InChI or CSID

Systematic names 1,2-dihydroxybenzene
Synonyms AIBN
Trade names Aspirin
Registry numbers 7732-18-5
SMILES O=C(OCC)C
InChl InChI=1/CH4/h1H4
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 12 results

Search term: QVUUUSJUORLECR (Found by InChIKey (skeleton match))
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
91655

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12-,13-,16-/m1/s1
C16H17N5O4343.3373262200
4252

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)
C16H17N5O4343.337391300
5036262

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12-,13-,16+/m0/s1
C16H17N5O4343.33733300
5415739

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13+,16-/m0/s1
C16H17N5O4343.33732100
5415740

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13+,16+/m0/s1
C16H17N5O4343.33732100
5415741

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13-,16-/m0/s1
C16H17N5O4343.33732100
5415742

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13-,16+/m0/s1
C16H17N5O4343.33732100
10131927

3 of 4 defined stereocentres - 3/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13?,16-/m1/s1
C16H17N5O4343.33732200
1072074

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12-,13+,16+/m1/s1
C16H17N5O4343.33732100
26361026

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12+,13-,16-/m1/s1
C16H17N5O4343.33732200
75552036

2 of 4 defined stereocentres - 2/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12?,13?,16-/m1/s1
C16H17N5O4343.33731100
23210711

3 of 4 defined stereocentres - 3/4 defined
InChI=1/C16H17N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-24H,6H2,(H,17,18,20)/t10-,12?,13+,16-/m1/s1
C16H17N5O4343.33731100

Advertisement